rss

Author index

May 1998, Volume 53, Issue 5

[Front cover][Table of contents]
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Ahmed, B

    • How long should Atrovent be given in acute asthma? Thorax 1998;53:5 363-367 doi:10.1136/thx.53.5.363

  2. Alifano, Marco

    • Detection of IgG and IgA against the mycobacterial antigen A60 in patients with extrapulmonary tuberculosis Thorax 1998;53:5 377-380 doi:10.1136/thx.53.5.377

  3. Arnold, A

    • How long should Atrovent be given in acute asthma? Thorax 1998;53:5 363-367 doi:10.1136/thx.53.5.363

B

  1. Bayston, S

    • How long should Atrovent be given in acute asthma? Thorax 1998;53:5 363-367 doi:10.1136/thx.53.5.363

  2. Britton, J

    • Genetics and pulmonary medicine: Introduction Thorax 1998;53:5 388 doi:10.1136/thx.53.5.388

  3. Brophy, C

    • How long should Atrovent be given in acute asthma? Thorax 1998;53:5 363-367 doi:10.1136/thx.53.5.363

  4. Buchanan, K D

    • Neurokinin A is the predominant tachykinin in human bronchoalveolar lavage fluid in normal and asthmatic subjects Thorax 1998;53:5 357-362 doi:10.1136/thx.53.5.357

C

  1. Coggon, David

    • Coal mining and chronic obstructive pulmonary disease: a review of the evidence Thorax 1998;53:5 398-407 doi:10.1136/thx.53.5.398

  2. Corkill, J E

    • Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia Thorax 1998;53:5 432-436 doi:10.1136/thx.53.5.432

  3. Coultas, David B

    • Health effects of passive smoking • 8: Passive smoking and risk of adult asthma and COPD: an update Thorax 1998;53:5 381-387 doi:10.1136/thx.53.5.381

  4. Covelli, Italo

    • Detection of IgG and IgA against the mycobacterial antigen A60 in patients with extrapulmonary tuberculosis Thorax 1998;53:5 377-380 doi:10.1136/thx.53.5.377

  5. COWAN, SIMONE

    • Bisphosphonates and glucocorticoid-induced osteoporosis: implications for patients with respiratory diseases Thorax 1998;53:5 331-332 doi:10.1136/thx.53.5.331

  6. Cross, L J M

    • Neurokinin A is the predominant tachykinin in human bronchoalveolar lavage fluid in normal and asthmatic subjects Thorax 1998;53:5 357-362 doi:10.1136/thx.53.5.357

D

  1. Davidson, Donald J

    • Genetics and pulmonary medicine • 1: The genetics of cystic fibrosis lung disease Thorax 1998;53:5 389-397 doi:10.1136/thx.53.5.389

  2. Davies, Robert J O

    • Cardiovascular aspects of obstructive sleep apnoea and their relevance to the assessment of the efficacy of nasal continuous positive airway pressure therapy Thorax 1998;53:5 416-418 doi:10.1136/thx.53.5.416

  3. Deary, Ian J

    • Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome Thorax 1998;53:5 341-345 doi:10.1136/thx.53.5.341

  4. Del Pezzo, Mariassunta

    • Detection of IgG and IgA against the mycobacterial antigen A60 in patients with extrapulmonary tuberculosis Thorax 1998;53:5 377-380 doi:10.1136/thx.53.5.377

  5. De Pascalis, Roberto

    • Detection of IgG and IgA against the mycobacterial antigen A60 in patients with extrapulmonary tuberculosis Thorax 1998;53:5 377-380 doi:10.1136/thx.53.5.377

  6. Douglas, Neil J

    • Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome Thorax 1998;53:5 341-345 doi:10.1136/thx.53.5.341
    • Systematic review of the efficacy of nasal CPAP Thorax 1998;53:5 414-415 doi:10.1136/thx.53.5.414

E

  1. Engleman, Heather M

    • Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome Thorax 1998;53:5 341-345 doi:10.1136/thx.53.5.341

  2. Ennis, M

    • Neurokinin A is the predominant tachykinin in human bronchoalveolar lavage fluid in normal and asthmatic subjects Thorax 1998;53:5 357-362 doi:10.1136/thx.53.5.357

  3. ERNST, PIERRE

    • Bisphosphonates and glucocorticoid-induced osteoporosis: implications for patients with respiratory diseases Thorax 1998;53:5 331-332 doi:10.1136/thx.53.5.331

F

  1. Faraone, Stanislao

    • Detection of IgG and IgA against the mycobacterial antigen A60 in patients with extrapulmonary tuberculosis Thorax 1998;53:5 377-380 doi:10.1136/thx.53.5.377

G

  1. Gallagher, M J

    • Chronic Burkholderia cepaciabronchiectasis in a non-cystic fibrosis individual Thorax 1998;53:5 430-432 doi:10.1136/thx.53.5.430
    • Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia Thorax 1998;53:5 432-436 doi:10.1136/thx.53.5.432

  2. Gibson, G J

    • Public health aspects of obstructive sleep apnoea Thorax 1998;53:5 408-409 doi:10.1136/thx.53.5.408

  3. GOVAN, J R

    • Burkholderia cepacia: another twist and a further threat Thorax 1998;53:5 333-334 doi:10.1136/thx.53.5.333

  4. Goyal, M

    • Pulmonary tuberculosis in Harare, Zimbabwe: analysis by spoligotyping Thorax 1998;53:5 346-350 doi:10.1136/thx.53.5.346

  5. GRANGE, JOHN M

    • Inhibition of T cell proliferation by human alveolar macrophages
      1. Commentator:
        • PATRICK G HOLT and
        • JOHN W UPHAM
      Thorax 1998;53:5 437 doi:10.1136/thx.53.5.437

  6. Greenstone, M

    • How long should Atrovent be given in acute asthma? Thorax 1998;53:5 363-367 doi:10.1136/thx.53.5.363

H

  1. Hart, C A

    • Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia Thorax 1998;53:5 432-436 doi:10.1136/thx.53.5.432

  2. Hassim, Zeenath

    • Injury to murine airway epithelial cells by pollen enzymes Thorax 1998;53:5 368-371 doi:10.1136/thx.53.5.368

  3. HAYWARD, A C

    • Typing of mycobacteria using spoligotyping Thorax 1998;53:5 329-330 doi:10.1136/thx.53.5.329

  4. Heaney, L G

    • Neurokinin A is the predominant tachykinin in human bronchoalveolar lavage fluid in normal and asthmatic subjects Thorax 1998;53:5 357-362 doi:10.1136/thx.53.5.357

  5. Heyderman, R S

    • Pulmonary tuberculosis in Harare, Zimbabwe: analysis by spoligotyping Thorax 1998;53:5 346-350 doi:10.1136/thx.53.5.346

  6. HOLGATE, STEPHEN T

    • Adenosine and adenosine antagonism in asthma
      1. Commentator:
        • STEPHEN T HOLGATE
      Thorax 1998;53:5 437 doi:10.1136/thx.53.5.437a

  7. HOLT, PATRICK G

    • Inhibition of T cell proliferation by human alveolar macrophages
      1. Commentator:
        • PATRICK G HOLT and
        • JOHN W UPHAM
      Thorax 1998;53:5 437 doi:10.1136/thx.53.5.437

  8. Hopkin, J

    • Genetics and pulmonary medicine: Introduction Thorax 1998;53:5 388 doi:10.1136/thx.53.5.388

I

  1. Inman, Mark

    • Measurement of airway hyperresponsiveness: new considerations Thorax 1998;53:5 419-424 doi:10.1136/thx.53.5.419

K

  1. Kingshott, Ruth N

    • Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome Thorax 1998;53:5 341-345 doi:10.1136/thx.53.5.341

  2. Kumar, Rakesh K

    • Injury to murine airway epithelial cells by pollen enzymes Thorax 1998;53:5 368-371 doi:10.1136/thx.53.5.368

  3. Kuo, Ping-Hung

    • Diagnosis of pulmonary arteriovenous malformations by colour Doppler ultrasound and amplitude ultrasound angiography Thorax 1998;53:5 372-376 doi:10.1136/thx.53.5.372

  4. Kuo, Sow-Hsong

    • Diagnosis of pulmonary arteriovenous malformations by colour Doppler ultrasound and amplitude ultrasound angiography Thorax 1998;53:5 372-376 doi:10.1136/thx.53.5.372

L

  1. Ledson, M J

    • Chronic Burkholderia cepaciabronchiectasis in a non-cystic fibrosis individual Thorax 1998;53:5 430-432 doi:10.1136/thx.53.5.430
    • Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia Thorax 1998;53:5 432-436 doi:10.1136/thx.53.5.432

  2. Liaw, Yuang-Shuang

    • Diagnosis of pulmonary arteriovenous malformations by colour Doppler ultrasound and amplitude ultrasound angiography Thorax 1998;53:5 372-376 doi:10.1136/thx.53.5.372

  3. Li, F

    • A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long term oral corticosteroid treatment Thorax 1998;53:5 351-356 doi:10.1136/thx.53.5.351

  4. Lötvall, Jan

    • Measurement of airway hyperresponsiveness: new considerations Thorax 1998;53:5 419-424 doi:10.1136/thx.53.5.419

  5. Luh, Kwen-Tay

    • Diagnosis of pulmonary arteriovenous malformations by colour Doppler ultrasound and amplitude ultrasound angiography Thorax 1998;53:5 372-376 doi:10.1136/thx.53.5.372

M

  1. Mackay, Thomas W

    • Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome Thorax 1998;53:5 341-345 doi:10.1136/thx.53.5.341

  2. Makombe, Robert

    • Pulmonary tuberculosis in Harare, Zimbabwe: analysis by spoligotyping Thorax 1998;53:5 346-350 doi:10.1136/thx.53.5.346

  3. Maronese, Sonia E

    • Injury to murine airway epithelial cells by pollen enzymes Thorax 1998;53:5 368-371 doi:10.1136/thx.53.5.368

  4. Marshall, B G

    • Pulmonary tuberculosis in Harare, Zimbabwe: analysis by spoligotyping Thorax 1998;53:5 346-350 doi:10.1136/thx.53.5.346

  5. Martin, Sascha E

    • Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome Thorax 1998;53:5 341-345 doi:10.1136/thx.53.5.341

  6. Mason, P R

    • Pulmonary tuberculosis in Harare, Zimbabwe: analysis by spoligotyping Thorax 1998;53:5 346-350 doi:10.1136/thx.53.5.346

  7. McGarvey, L P A

    • Neurokinin A is the predominant tachykinin in human bronchoalveolar lavage fluid in normal and asthmatic subjects Thorax 1998;53:5 357-362 doi:10.1136/thx.53.5.357

  8. McGivern, D

    • How long should Atrovent be given in acute asthma? Thorax 1998;53:5 363-367 doi:10.1136/thx.53.5.363

  9. Moniz, C

    • A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long term oral corticosteroid treatment Thorax 1998;53:5 351-356 doi:10.1136/thx.53.5.351

  10. MORIN, SUZANNE

    • Bisphosphonates and glucocorticoid-induced osteoporosis: implications for patients with respiratory diseases Thorax 1998;53:5 331-332 doi:10.1136/thx.53.5.331

O

  1. O’Byrne, Paul

    • Measurement of airway hyperresponsiveness: new considerations Thorax 1998;53:5 419-424 doi:10.1136/thx.53.5.419

P

  1. Pack, S

    • A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long term oral corticosteroid treatment Thorax 1998;53:5 351-356 doi:10.1136/thx.53.5.351

  2. PERSSON, CARL

    • Adenosine and adenosine antagonism in asthma
      1. Commentator:
        • STEPHEN T HOLGATE
      Thorax 1998;53:5 437 doi:10.1136/thx.53.5.437a

  3. Pitt, P

    • A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long term oral corticosteroid treatment Thorax 1998;53:5 351-356 doi:10.1136/thx.53.5.351

  4. Porteous, David J

    • Genetics and pulmonary medicine • 1: The genetics of cystic fibrosis lung disease Thorax 1998;53:5 389-397 doi:10.1136/thx.53.5.389

R

  1. Rizzato, Gianfranco

    • Clinical impact of bone and calcium metabolism changes in sarcoidosis Thorax 1998;53:5 425-429 doi:10.1136/thx.53.5.425

  2. Roberts, P

    • Pulmonary tuberculosis in Harare, Zimbabwe: analysis by spoligotyping Thorax 1998;53:5 346-350 doi:10.1136/thx.53.5.346

  3. RUDD, ROBIN

    • Coal miners’ respiratory disease litigation Thorax 1998;53:5 337-340 doi:10.1136/thx.53.5.337

S

  1. SEATON, ANTHONY

    • The new prescription: industrial injuries benefits for smokers? Thorax 1998;53:5 335-336 doi:10.1136/thx.53.5.335

  2. Shaw, C

    • Neurokinin A is the predominant tachykinin in human bronchoalveolar lavage fluid in normal and asthmatic subjects Thorax 1998;53:5 357-362 doi:10.1136/thx.53.5.357

  3. Shaw, R J

    • Pulmonary tuberculosis in Harare, Zimbabwe: analysis by spoligotyping Thorax 1998;53:5 346-350 doi:10.1136/thx.53.5.346

  4. Sheldon, Trevor

    • Sleep apnoea and its impact on public health Thorax 1998;53:5 410-413 doi:10.1136/thx.53.5.410

  5. Sofia, Matteo

    • Detection of IgG and IgA against the mycobacterial antigen A60 in patients with extrapulmonary tuberculosis Thorax 1998;53:5 377-380 doi:10.1136/thx.53.5.377

T

  1. Taylor, Anthony Newman

    • Coal mining and chronic obstructive pulmonary disease: a review of the evidence Thorax 1998;53:5 398-407 doi:10.1136/thx.53.5.398

  2. Todd, P

    • A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long term oral corticosteroid treatment Thorax 1998;53:5 351-356 doi:10.1136/thx.53.5.351

U

  1. UPHAM, JOHN W

    • Inhibition of T cell proliferation by human alveolar macrophages
      1. Commentator:
        • PATRICK G HOLT and
        • JOHN W UPHAM
      Thorax 1998;53:5 437 doi:10.1136/thx.53.5.437

  2. Ushewokunze, S

    • Pulmonary tuberculosis in Harare, Zimbabwe: analysis by spoligotyping Thorax 1998;53:5 346-350 doi:10.1136/thx.53.5.346

V

  1. Van Embden, J D A

    • Pulmonary tuberculosis in Harare, Zimbabwe: analysis by spoligotyping Thorax 1998;53:5 346-350 doi:10.1136/thx.53.5.346

W

  1. Walshaw, M J

    • Chronic Burkholderia cepaciabronchiectasis in a non-cystic fibrosis individual Thorax 1998;53:5 430-432 doi:10.1136/thx.53.5.430
    • Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia Thorax 1998;53:5 432-436 doi:10.1136/thx.53.5.432

  2. Wang, Hao-Chien

    • Diagnosis of pulmonary arteriovenous malformations by colour Doppler ultrasound and amplitude ultrasound angiography Thorax 1998;53:5 372-376 doi:10.1136/thx.53.5.372

  3. WATSON, J M

    • Typing of mycobacteria using spoligotyping Thorax 1998;53:5 329-330 doi:10.1136/thx.53.5.329

  4. WEBB, A K

    • Burkholderia cepacia: another twist and a further threat Thorax 1998;53:5 333-334 doi:10.1136/thx.53.5.333

  5. Webber, D

    • A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long term oral corticosteroid treatment Thorax 1998;53:5 351-356 doi:10.1136/thx.53.5.351

  6. Wright, John

    • Sleep apnoea and its impact on public health Thorax 1998;53:5 410-413 doi:10.1136/thx.53.5.410

Y

  1. Yang, Pan-Chyr

    • Diagnosis of pulmonary arteriovenous malformations by colour Doppler ultrasound and amplitude ultrasound angiography Thorax 1998;53:5 372-376 doi:10.1136/thx.53.5.372

  2. Yu, Chong-Jen

    • Diagnosis of pulmonary arteriovenous malformations by colour Doppler ultrasound and amplitude ultrasound angiography Thorax 1998;53:5 372-376 doi:10.1136/thx.53.5.372

Z

  1. Zizhou, S

    • Pulmonary tuberculosis in Harare, Zimbabwe: analysis by spoligotyping Thorax 1998;53:5 346-350 doi:10.1136/thx.53.5.346

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.